JP2013541706A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013541706A5 JP2013541706A5 JP2013528474A JP2013528474A JP2013541706A5 JP 2013541706 A5 JP2013541706 A5 JP 2013541706A5 JP 2013528474 A JP2013528474 A JP 2013528474A JP 2013528474 A JP2013528474 A JP 2013528474A JP 2013541706 A5 JP2013541706 A5 JP 2013541706A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarker
- subject
- peptide fragment
- apolipoprotein
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2010904249A AU2010904249A0 (en) | 2010-09-21 | Biomarkers associated with pre-diabetes,diabetes and diabetes related conditions | |
| AU2010904249 | 2010-09-21 | ||
| PCT/AU2011/001212 WO2012037603A1 (en) | 2010-09-21 | 2011-09-20 | Biomarkers associated with pre-diabetes, diabetes and diabetes related conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017136403A Division JP2017223682A (ja) | 2010-09-21 | 2017-07-12 | 糖尿病前症、糖尿病、および糖尿病関連症状に関連するバイオマーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013541706A JP2013541706A (ja) | 2013-11-14 |
| JP2013541706A5 true JP2013541706A5 (enExample) | 2014-11-06 |
| JP6271250B2 JP6271250B2 (ja) | 2018-01-31 |
Family
ID=45873304
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013528474A Active JP6271250B2 (ja) | 2010-09-21 | 2011-09-20 | 糖尿病前症、糖尿病、および糖尿病関連症状に関連するバイオマーカー |
| JP2017136403A Pending JP2017223682A (ja) | 2010-09-21 | 2017-07-12 | 糖尿病前症、糖尿病、および糖尿病関連症状に関連するバイオマーカー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017136403A Pending JP2017223682A (ja) | 2010-09-21 | 2017-07-12 | 糖尿病前症、糖尿病、および糖尿病関連症状に関連するバイオマーカー |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US20130177544A1 (enExample) |
| EP (3) | EP3151012B1 (enExample) |
| JP (2) | JP6271250B2 (enExample) |
| CN (2) | CN103299192B (enExample) |
| AU (2) | AU2011305050B2 (enExample) |
| BR (1) | BR112013006764B1 (enExample) |
| CA (1) | CA2811654C (enExample) |
| ES (2) | ES2928585T3 (enExample) |
| RU (1) | RU2596486C2 (enExample) |
| SG (1) | SG188527A1 (enExample) |
| WO (1) | WO2012037603A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3151012B1 (en) * | 2010-09-21 | 2018-03-21 | Proteomics International Pty Ltd | Biomarkers associated with diabetic nephropathy |
| US9928345B2 (en) | 2012-06-08 | 2018-03-27 | Liposciences, Inc. | Multiple-marker risk parameters predictive of conversion to diabetes |
| US9361429B2 (en) | 2012-06-08 | 2016-06-07 | Liposcience, Inc. | Multi-parameter diabetes risk evaluations |
| WO2014034168A1 (ja) * | 2012-08-30 | 2014-03-06 | Hashida Seiichi | 早期腎障害の評価マーカーとその測定方法 |
| US11699527B2 (en) * | 2013-03-14 | 2023-07-11 | Otraces, Inc. | Method for improving disease diagnosis using measured analytes |
| CN103473569A (zh) * | 2013-09-22 | 2013-12-25 | 江苏美伦影像系统有限公司 | 基于svm的医学影像分类方法 |
| JP5925391B2 (ja) * | 2013-10-16 | 2016-05-25 | 日本水産株式会社 | ペプチド又はその酸付加塩、飲食品、及び糖尿病予防等の組成物 |
| US10267806B2 (en) | 2014-04-04 | 2019-04-23 | Mayo Foundation For Medical Education And Research | Isotyping immunoglobulins using accurate molecular mass |
| US11209439B2 (en) | 2015-09-24 | 2021-12-28 | Mayo Foundation For Medical Education And Research | Identification of immunoglobulin free light chains by mass spectrometry |
| JP6952056B2 (ja) | 2016-01-22 | 2021-10-20 | オートレイシーズ, インク.Otraces, Inc. | 疾患診断を改善するシステム及び方法 |
| US10955420B2 (en) | 2016-09-07 | 2021-03-23 | Mayo Foundation For Medical Education And Research | Identification and monitoring of cleaved immunoglobulins by molecular mass |
| WO2018088521A1 (ja) | 2016-11-11 | 2018-05-17 | 大塚製薬株式会社 | 肝の糖取込み能評価方法 |
| PL3358355T3 (pl) * | 2017-02-04 | 2024-04-08 | Warszawski Uniwersytet Medyczny | Zastosowanie surowiczych peroksyredoksyn dwucysteinowych (2-Cys-PRDX) jako biomarkerów przewlekłej choroby nerek (PChN, ang. CKD) takiej jak toczniowe zapalenie nerek (LN), nefropatia IgA (IgAN) i autosomalna dominująca wielotorbielowatość nerek (ADPKD) użytecznych do diagnozowania tych chorób i sposoby różnicowania tych chorób |
| CN106645757B (zh) * | 2017-03-13 | 2019-01-15 | 新疆医科大学 | 一种诊断早发糖尿病mody的血清蛋白标志物组及其应用 |
| CN107144620A (zh) * | 2017-03-31 | 2017-09-08 | 兰州百源基因技术有限公司 | 糖尿病肾病检测标志物 |
| CN110914691B (zh) | 2017-03-31 | 2024-07-26 | 奎斯特诊断投资有限公司 | 用于定量胰岛素和c-肽的方法 |
| CN108732253A (zh) * | 2017-04-14 | 2018-11-02 | 杭州量康科技有限公司 | 用于血清蛋白质定量测定的肽段组合物及测定方法 |
| US12153052B2 (en) | 2017-09-13 | 2024-11-26 | Mayo Foundation For Medical Education And Research | Identification and monitoring of immunoglobulin J chains |
| US11946937B2 (en) | 2017-09-13 | 2024-04-02 | Mayo Foundation For Medical Education And Research | Identification and monitoring of apoptosis inhibitor of macrophage |
| RU2687256C1 (ru) * | 2018-03-26 | 2019-05-08 | Федеральное Государственное бюджетное образовательное учреждение высшего образования Дагестанский государственный медицинский университет Министерства здравоохранения Российской Федерации Даггосмедуниверситет | Способ персонализированного лечения хронической болезни почек у больных с диабетической нефропатией |
| CA3103150A1 (en) * | 2018-06-21 | 2019-12-20 | China Medical University | Protein biomarkers for nephropathy and applications thereof |
| JP7419340B2 (ja) * | 2018-08-08 | 2024-01-22 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | タンパク質バイオマーカーを定量するためのｌｃ－ｍｓ／ｍｓの使用 |
| CN110286234B (zh) * | 2019-07-02 | 2023-03-24 | 安肽和(杭州)医疗科技有限公司 | 尿液中妊娠糖尿病的蛋白质标志物及其在早期诊断中的用途 |
| JP2023509677A (ja) * | 2020-01-10 | 2023-03-09 | ソマロジック オペレーティング カンパニー インコーポレイテッド | 耐糖能異常障害を決定する方法 |
| CN111876479A (zh) * | 2020-06-29 | 2020-11-03 | 中国人民解放军总医院 | 基于尿沉渣特定微小rna无创鉴别诊断糖尿病肾病/非糖尿病性肾病方面的应用 |
| CN117310148A (zh) * | 2023-09-11 | 2023-12-29 | 杭州珞米医疗科技有限公司 | 一种蛋白标志物作为生物标志物的用途 |
| CN118534127A (zh) * | 2024-04-12 | 2024-08-23 | 郑州大学 | 补体h因子相关蛋白作为糖尿病肾病诊断的生物标志物的应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100640201B1 (ko) * | 2004-12-07 | 2006-10-30 | (주) 대홍기업 | 히트파이프가 설치된 도어 조립체 및 이 도어 조립체를채택한 김치저장고 |
| CN101166981A (zh) * | 2005-04-11 | 2008-04-23 | 阿斯利康(瑞典)有限公司 | 一种用于诊断 2型糖尿病、代谢综合征、亚临床动脉粥样硬化、心肌梗死、中风或糖尿病的临床表现的方法和试剂盒 |
| WO2006122043A2 (en) * | 2005-05-05 | 2006-11-16 | Fibrogen, Inc. | Diagnostic marker for diabetic vascular complications |
| WO2007028636A1 (en) * | 2005-09-09 | 2007-03-15 | Medizinische Universität Innsbruck | Method for predicting the progression of chronic kidney disease by measuring apolipoprotein a-iv |
| US20070218519A1 (en) * | 2005-10-11 | 2007-09-20 | Tethys Bioscience, Inc. | Diabetes-associated markers and methods of use thereof |
| US20070111245A1 (en) * | 2005-11-09 | 2007-05-17 | Ravi Thadhani | Predicting diabetic nephropathy |
| CN101361001A (zh) * | 2006-01-20 | 2009-02-04 | 马赛奎斯诊断和治疗有限公司 | 诊断肾病的方法和标志物 |
| EP2005172A4 (en) * | 2006-03-23 | 2009-05-06 | Emelita De Guzman Breyer | APOLIPOPROTEIN-FINGERPRINT PROCESS |
| EP2021502A4 (en) * | 2006-05-09 | 2010-08-25 | Mas Metabolic Analytical Servi | GENES AND ATYPICAL MARKERS IN TYPE 2 DIABETES AND OBESITY |
| KR100792630B1 (ko) * | 2006-07-05 | 2008-01-09 | 고려대학교 산학협력단 | 당뇨병성 신증 진단용 바이오 마커 |
| EP2469283B1 (en) * | 2006-09-08 | 2014-01-15 | The Chancellor, Masters and Scholars of the University of Oxford | Clinical diagnosis of hepatic fibrosis using human serum APOL1 as biomarker |
| US8039227B2 (en) * | 2007-09-20 | 2011-10-18 | University Of Louisville Research Foundation, Inc. | Peptide biomarkers predictive of renal function decline and kidney disease |
| WO2009103312A1 (en) * | 2008-02-19 | 2009-08-27 | Ludwig-Maximilians-Universität | Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases |
| WO2009126271A1 (en) * | 2008-04-11 | 2009-10-15 | China Synthetic Rubber Corporation | Methods, agents and kits for the detection of cancer |
| US8673644B2 (en) * | 2008-05-13 | 2014-03-18 | Battelle Memorial Institute | Serum markers for type II diabetes mellitus |
| EP2307544A4 (en) * | 2008-06-13 | 2012-09-05 | Prognomix Inc | GENETIC COMPONENT OF COMPLICATIONS IN TYPE 2 DIABETES |
| EP2307050A4 (en) * | 2008-07-04 | 2012-07-25 | Ono Pharmaceutical Co | USE OF A EFFECTIVENESS MARKER TO OPTIMIZE THE THERAPEUTIC EFFECTIVENESS OF AN ANTI-HUMAN PD-1 ANTIBODY ON CANCERS |
| WO2010005982A2 (en) * | 2008-07-07 | 2010-01-14 | The General Hospital Corporation | Multiplexed biomarkers of insulin resistance |
| US8735443B2 (en) * | 2008-10-21 | 2014-05-27 | Kuwait University | Method of treating diabetes-related vascular complications |
| CA2750818A1 (en) * | 2009-01-27 | 2010-08-05 | Proteogenix, Inc. | Biomarkers for detection of neonatal sepsis in biological fluid |
| DK2623517T3 (en) * | 2009-01-28 | 2015-11-23 | Ind Tech Res Inst | Urine and serum biomarkers associated with diabetic nephropathy |
| EP2510361A4 (en) * | 2009-12-11 | 2013-07-17 | Purdue Research Foundation | DETECTION OF OXIDIZED POLYPEPTIDES |
| JPWO2011145725A1 (ja) * | 2010-05-20 | 2013-07-22 | 宮崎 徹 | Ａｉｍ関連疾患の診断方法及び診断用キット |
| EP3151012B1 (en) * | 2010-09-21 | 2018-03-21 | Proteomics International Pty Ltd | Biomarkers associated with diabetic nephropathy |
-
2011
- 2011-09-20 EP EP16194985.4A patent/EP3151012B1/en active Active
- 2011-09-20 RU RU2013113927/15A patent/RU2596486C2/ru active
- 2011-09-20 EP EP11826214.6A patent/EP2619592A4/en not_active Ceased
- 2011-09-20 CN CN201180053583.9A patent/CN103299192B/zh active Active
- 2011-09-20 WO PCT/AU2011/001212 patent/WO2012037603A1/en not_active Ceased
- 2011-09-20 SG SG2013018593A patent/SG188527A1/en unknown
- 2011-09-20 CA CA2811654A patent/CA2811654C/en active Active
- 2011-09-20 ES ES18155797T patent/ES2928585T3/es active Active
- 2011-09-20 BR BR112013006764-0A patent/BR112013006764B1/pt active IP Right Grant
- 2011-09-20 JP JP2013528474A patent/JP6271250B2/ja active Active
- 2011-09-20 US US13/824,359 patent/US20130177544A1/en not_active Abandoned
- 2011-09-20 CN CN201610302678.4A patent/CN105974123A/zh active Pending
- 2011-09-20 ES ES16194985.4T patent/ES2665910T3/es active Active
- 2011-09-20 EP EP18155797.6A patent/EP3343226B1/en active Active
- 2011-09-20 AU AU2011305050A patent/AU2011305050B2/en active Active
-
2014
- 2014-05-14 US US14/277,371 patent/US9146243B2/en active Active
-
2015
- 2015-04-29 AU AU2015202230A patent/AU2015202230B2/en active Active
- 2015-08-24 US US14/833,199 patent/US9733259B2/en active Active
-
2017
- 2017-06-26 US US15/632,753 patent/US10191067B2/en active Active
- 2017-07-12 JP JP2017136403A patent/JP2017223682A/ja active Pending
-
2018
- 2018-12-13 US US16/218,777 patent/US20190107546A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013541706A5 (enExample) | ||
| CA2781754C (en) | Diagnostic method for detecting acute kidney injury using heat shock protein 72 as a sensitive biomarker | |
| Scirica | Use of biomarkers in predicting the onset, monitoring the progression, and risk stratification for patients with type 2 diabetes mellitus | |
| Lippi et al. | Neutrophil gelatinase-associated lipocalin (NGAL): the laboratory perspective. | |
| JP2012529015A (ja) | 腎臓疾患評価用新規バイオマーカー | |
| WO2010002911A3 (en) | Methods and materials for monitoring myeloma using quantitative mass spetrometry | |
| JP2010509575A5 (enExample) | ||
| NZ619883A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| JP2011510327A5 (enExample) | ||
| JP2008241705A (ja) | 透析の必要性を予測するためのｂｎｐ型ペプチド類の使用 | |
| Shaker et al. | Serum and urinary transforming growth factor beta 1 as biochemical markers in diabetic nephropathy patients | |
| Sangoi et al. | Urinary inflammatory cytokines as indicators of kidney damage in type 2 diabetic patients | |
| Xiang et al. | Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification | |
| EA201390293A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| US20110263438A1 (en) | Diagnosis and complication risk assessment of pancreatic diabetes using procalcitonin | |
| Raghav et al. | Glycated albumin in chronic kidney disease: Pathophysiologic connections | |
| Hassan et al. | Urinary cystatin C as a biomarker of early renal dysfunction in type 2 diabetic patients | |
| Jung et al. | Novel biomarkers for diabetic kidney disease | |
| EA201290627A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| Javadi et al. | Interrelationship of βeta-2 microglobulin, blood urea nitrogen and creatinine in streptozotocin-induced diabetes mellitus in rabbits | |
| Elie et al. | Local enrichment of fatty acid-binding protein 4 in the pericardial cavity of cardiovascular disease patients | |
| Kushnir et al. | A depletion strategy for improved detection of human proteins from urine | |
| DK2626704T3 (en) | Diagnosis of pancreatic diabetes in patients with normal blood leucocyte counts using procalcitonin | |
| Cöl et al. | Microalbuminuria: prevalence in hypertensives and diabetics. | |
| EP1941274A1 (en) | Method for predicting the progression of chronic kidney disease by measuring apolipoprotein a-iv |